JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on August 27, 2003; DOI: 10.1124/jpet.103.054593


0022-3565/03/3071-34-41$20.00
JPET 307:34-41, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.103.054593v1
307/1/34    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ravna, A. W.
Right arrow Articles by Dahl, S. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ravna, A. W.
Right arrow Articles by Dahl, S. G.

CELLULAR AND MOLECULAR

Molecular Mechanism of Citalopram and Cocaine Interactions with Neurotransmitter Transporters

Aina Westrheim Ravna, Ingebrigt Sylte, and Svein G. Dahl

Department of Pharmacology, Institute of Medical Biology, University of Tromsø, Tromsø, Norway

The selective serotonin reuptake inhibitors (SSRIs) and cocaine bind to the neural serotonin (5-HT) transporter (SERT) and thus inhibit presynaptic reuptake of 5-HT and elevate its concentration in the synaptic cleft. Cocaine also binds to the dopamine transporter (DAT) and to the noradrenaline transporter (NET) and inhibits presynaptic reuptake of dopamine and noradrenaline. SERT, DAT, and NET belong to the sodium/neurotransmitter symporter family, which is predicted to have a molecular structure with 12 transmembrane {alpha}-helices (TMHs) and intracellular amino- and carboxy terminals. We used an electron density projection map of the Escherichia coli Na+/H+ anti-porter, and site-directed mutagenesis data on DAT and SERT to construct 3-dimensional molecular models of SERT, DAT and NET. These models were used to simulate the molecular interaction mechanisms of the SSRI, S-citalopram, its less potent enantiomer, R-citalopram and of cocaine with the transporters. In the SERT model, a single amino acid (Tyr95) in TMH1 determined the transporter selectivity of S-citalopram for SERT over DAT and NET. A dipole-dipole interaction was formed between the hydroxy group of Tyr95 in SERT and the nitril group of S-citalopram, but could not be formed by S-citalopram in DAT and NET where the corresponding amino acid is a phenylalanine. The lower binding affinity of R-citalopram may be due to sterical hindrance at the binding site. The tropane ring of cocaine interacted with Tyr95 in SERT and with the corresponding phenylalanines in NET and DAT. This may explain why cocaine, but not S-citalopram, has high binding affinity to all three transporters.


Received for publication May 20, 2003
Accepted June 20, 2003.

Address correspondence to: Dr. Svein G. Dahl, Department of Pharmacology, I.M.B., University of Tromsø, N-9037 Tromsø, Norway. E-mail: sgd{at}fagmed.uit.no




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
F. A. Paczkowski, I. A. Sharpe, S. Dutertre, and R. J. Lewis
{chi}-Conotoxin and Tricyclic Antidepressant Interactions at the Norepinephrine Transporter Define a New Transporter Model
J. Biol. Chem., June 15, 2007; 282(24): 17837 - 17844.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
S. G. Dahl and I. Sylte
From genomics to drug targets
J Psychopharmacol, July 1, 2006; 20(4_suppl): 95 - 99.
[Abstract] [PDF]


Home page
J. Biol. Chem.Home page
L. K. Henry, J. R. Field, E. M. Adkins, M. L. Parnas, R. A. Vaughan, M.-F. Zou, A. H. Newman, and R. D. Blakely
Tyr-95 and Ile-172 in Transmembrane Segments 1 and 3 of Human Serotonin Transporters Interact to Establish High Affinity Recognition of Antidepressants
J. Biol. Chem., January 27, 2006; 281(4): 2012 - 2023.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. B. Larsen, B. Elfving, and O. Wiborg
The Chicken Serotonin Transporter Discriminates between Serotonin-selective Reuptake Inhibitors: A SPECIES-SCANNING MUTAGENESIS STUDY
J. Biol. Chem., October 1, 2004; 279(40): 42147 - 42156.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
S. G. Dahl, I. Sylte, and A. W. Ravna
Structures and Models of Transporter Proteins
J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 853 - 860.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.